Translation and Validation of the Persian Version of the Communication and Language Assessment Questionnaire for Persons with Multiple Sclerosis (P-CLAMS)
Archives of Clinical Neuropsychology · 2025
DOI: 10.1093/arclin/acaf060 ↗Kurz gefasst
Validierungsstudie in der Zeitschrift Archives of Clinical Neuropsychology, 2025. Verfasst von Aghaei Fatemeh und 5 weiteren Autor:innen. Beteiligte Einrichtung: Contemplative Studies Centre, Melbourne School of Psychological Sciences, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melb…. Hauptthemen laut MEDLINE: Multiple Sclerosis, Patient Reported Outcome Measures, Communication Disorders, Communication. Die Arbeit nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
Persons with multiple sclerosis (MS) can experience communication changes, which can significantly impact their quality of life. To explore and help address these challenges, patient-reported outcome measures (P-CLAMS) can be valuable tools in both research and clinical practice. They can help track symptom progression, support patient-centered care, assess the effectiveness of service delivery, and complement clinical assessments. This study aimed to translate and validate the Persian version of the Communication and Language Assessment Questionnaire for Persons with Multiple Sclerosis (P-CLAMS).
Method
The adaptation and translation of the questionnaire occurred in two phases: (1) translation and cultural adaptation and (2) validity and reliability. The final version of the P-CLAMS consists of 11 items with one component factor (communication/language).
Results
Significant differences were observed in construct and criterion validity measures. Confirmatory factor analysis indicated that the P-CLAMS is a unidimensional measure for assessing communication difficulties in MS. The internal consistency was high (α = 0.92), and test/retest reliability was acceptable (ICC = 0.89). Additionally, the P-CLAMS effectively discriminated between people with MS (PwMS) and healthy controls.
Conclusion
The psychometric evaluation demonstrated that the Persian version of the CLAMS (P-CLAMS) has good validity and reliability. The P-CLAMS can be a valuable tool for clinicians and researchers to assess communication changes in PwMS and evaluate intervention effectiveness.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Contemplative Studies Centre, Melbourne School of Psychological Sciences, Faculty of Medicine, Dentistry, and Health Sciences, The University of Melbourne, Melbourne, Victoria, Australia.
- Department of Speech Therapy, Paramedical Sciences Faculty, Mashhad University of Medical Sciences, Mashhad, Iran.
- Department of Speech Therapy, School of Rehabilitation Sciences, Isfahan University of Medical Sciences, Isfahan, Iran.
- Department of Communicative Sciences and Disorders, Michigan State University, East Lansing, Michigan, USA.
- Discipline of Speech Pathology, Faculty of Medicine and Health, The University of Sydney, Camperdown, NSW, Australia.
ORCID-Profile: Ghaemi Hamide
Zitieren
APA
Fatemeh, A., Shima, R., Maryam, A., Fatemeh, H., Hamide, G., & Sarah, E. W. (2025). Translation and Validation of the Persian Version of the Communication and Language Assessment Questionnaire for Persons with Multiple Sclerosis (P-CLAMS). Archives of Clinical Neuropsychology. https://doi.org/10.1093/arclin/acaf060
Vancouver
Fatemeh A, Shima R, Maryam A, Fatemeh H, Hamide G, Sarah EW. Translation and Validation of the Persian Version of the Communication and Language Assessment Questionnaire for Persons with Multiple Sclerosis (P-CLAMS). Archives of Clinical Neuropsychology. 2025. doi:10.1093/arclin/acaf060
BibTeX
@article{Fatemeh2025,
author = {Fatemeh, Aghaei and Shima, Rahmani and Maryam, Azarinfar and Fatemeh, HaresAbadi and Hamide, Ghaemi and Sarah, El-Wahsh},
title = {Translation and Validation of the Persian Version of the Communication and Language Assessment Questionnaire for Persons with Multiple Sclerosis (P-CLAMS)},
journal = {Archives of Clinical Neuropsychology},
year = {2025},
doi = {10.1093/arclin/acaf060}
}
EUVIMED